Table 2 Distribution of individual characteristics at baseline (T0) (n = 39). C: Group control, CHX 0.12% MW; CX: Group test, CHX 0.09% + HA, polylysine, xylitol, and Citrox®; P: Group test, MW containing natural extracts
Variables | C | CX | P | Global p-value |
|---|---|---|---|---|
Male, N(%) | 5 (45.0%) | 6 (37.5%) | 3 (25.0%) | 0.59 |
Female, N(%) | 6 (55.0%) | 10 (62.5%) | 9 (75.0%) | 0.59 |
Age (mean ± sd) | 34.7 ± 13.2 | 31.6 ± 11.6 | 29.7 ± 7.9 | 0.06 |
Smokers, N (%) | 2 (27.3%) | 6 (55.0%) | 2 (27.3%) | 0.08 |
% Bleeding (mean ± sd) | 39.31 ± 1.15 | 36.87 ± 0.94 | 39.04 ± 1.09 | 0.65 |
≥ 30% Bleeding sites | 63.6% | 56.2% | 75.0% | 0.22 |
< 30% Bleeding sites | 36.4% | 43.8% | 25.0% | 0.50 |